Swiss Life Asset Management’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$285K Buy
6,033
+161
+3% +$8.27K ﹤0.01% 1297
2026
Q1
$348K Buy
5,872
+865
+17% +$56.1K ﹤0.01% 1053
2025
Q4
$309K Buy
+5,007
New +$306K ﹤0.01% 1007

Other funds holding PBH

Swiss Life Asset Management's PBH Position: Q2 2026 in Review

Swiss Life Asset Management increased its Prestige Consumer Healthcare (PBH) stake by 2.7% in Q2 2026, buying an estimated $8.27K and bringing the position to 6,033 shares worth $285K. The position accounts for ﹤0.01% of the portfolio, ranked #1297.

Swiss Life Asset Management first reported a position in PBH in Q4 2025 and has held it in 3 quarters since. The position peaked at $348K in Q1 2026. 201 funds tracked by Wall St. Rank hold PBH as of Q2 2026.

  • Swiss Life Asset Management held 6,033 shares of Prestige Consumer Healthcare worth $285K as of Q2 2026.
  • Swiss Life Asset Management bought 161 Prestige Consumer Healthcare shares in Q2 2026, an estimated $8.27K.
  • Prestige Consumer Healthcare made up ﹤0.01% of Swiss Life Asset Management's portfolio in Q2 2026, its #1297 holding.
  • Swiss Life Asset Management first reported a position in Prestige Consumer Healthcare in Q4 2025 and has held it in 3 quarters since.
  • Swiss Life Asset Management's Prestige Consumer Healthcare position peaked at $348K in Q1 2026.
  • 201 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q2 2026.

Based on Swiss Life Asset Management's 13F filing for Q2 2026, filed 29 Jul 2026.